-
1
-
-
0003160442
-
Clinical appraisal of the narcotic power of methadone and its isomers
-
Denton J.E., and Beecher H.K. Clinical appraisal of the narcotic power of methadone and its isomers. JAMA 141 (1949) 1146-1153
-
(1949)
JAMA
, vol.141
, pp. 1146-1153
-
-
Denton, J.E.1
Beecher, H.K.2
-
2
-
-
0028970418
-
2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine
-
2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine. Life Sci 56 2 (1995) 45-50
-
(1995)
Life Sci
, vol.56
, Issue.2
, pp. 45-50
-
-
Kristensen, K.1
Christensen, C.B.2
Christrup, L.L.3
-
3
-
-
0019956720
-
Pharmacokinetics of methadone during maintenance treatment: adaptive changes during the induction phase
-
Nilsson M.J., Anggard E., Holmstrand H., et al. Pharmacokinetics of methadone during maintenance treatment: adaptive changes during the induction phase. Eur J Clin Pharmacol 22 4 (1982) 343-349
-
(1982)
Eur J Clin Pharmacol
, vol.22
, Issue.4
, pp. 343-349
-
-
Nilsson, M.J.1
Anggard, E.2
Holmstrand, H.3
-
4
-
-
0029125290
-
Custom-made capsules and suppositories of methadone for patients on high-dose opioids for cancer pain
-
Bruera E., Watanabe S., Fainsinger R.L., et al. Custom-made capsules and suppositories of methadone for patients on high-dose opioids for cancer pain. Pain 62 2 (1995) 141-146
-
(1995)
Pain
, vol.62
, Issue.2
, pp. 141-146
-
-
Bruera, E.1
Watanabe, S.2
Fainsinger, R.L.3
-
5
-
-
0032808428
-
Subcutaneous methadone in terminally ill patients: manageable local toxicity
-
Matthew P., and Storey P. Subcutaneous methadone in terminally ill patients: manageable local toxicity. J Pain Symptom Manage 18 (1999) 49-52
-
(1999)
J Pain Symptom Manage
, vol.18
, pp. 49-52
-
-
Matthew, P.1
Storey, P.2
-
6
-
-
0026181327
-
The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients
-
Bruera E., Kuehn N., Miller M.J., Selmser P., and Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7 2 (1991) 6-9
-
(1991)
J Palliat Care
, vol.7
, Issue.2
, pp. 6-9
-
-
Bruera, E.1
Kuehn, N.2
Miller, M.J.3
Selmser, P.4
Macmillan, K.5
-
7
-
-
0034194414
-
Validation of the Edmonton Symptom Assessment Scale
-
Chang V.T., Hwang S.S., and Feuerman M. Validation of the Edmonton Symptom Assessment Scale. Cancer 88 9 (2000) 2164-2171
-
(2000)
Cancer
, vol.88
, Issue.9
, pp. 2164-2171
-
-
Chang, V.T.1
Hwang, S.S.2
Feuerman, M.3
-
8
-
-
25144439516
-
Intermittent subcutaneous methadone administration in the management of cancer pain
-
Centeno C., and Vara F. Intermittent subcutaneous methadone administration in the management of cancer pain. J Pain Palliat Care Pharmacother 19 2 (2005) 7-12
-
(2005)
J Pain Palliat Care Pharmacother
, vol.19
, Issue.2
, pp. 7-12
-
-
Centeno, C.1
Vara, F.2
-
9
-
-
0026759376
-
Comment on Bruera et al. Local toxicity with subcutaneous methadone. Experience of two centers
-
Bohrer H., and Schmidt H. Comment on Bruera et al. Local toxicity with subcutaneous methadone. Experience of two centers. Pain 50 3 (1992) 373
-
(1992)
Pain
, vol.50
, Issue.3
, pp. 373
-
-
Bohrer, H.1
Schmidt, H.2
|